Description

Marijuana just moved off Schedule 1, but the risk didn’t disappear. 

It just got more complicated. Get clear on what actually changed, what didn’t, and what your agency needs to do next before the regulators do it for you. 

KEY WEBINAR TAKEAWAYS 

• How historic marijuana rescheduling does — and does not — impact hospice and home care company employees, patients, and business processes
• Current legal status of medical marijuana in light of historic rescheduling 
• How reclassification affects your marijuana policy and procedures

BONUS MATERIALS 

• Whitepaper: Marijuana Policy & Best Practices: Handling Employee Medical & Recreational Use
• Marijuana Rules: Guidelines for Creating Effective Cannabis Policy & Procedures 

WEBINAR DETAILS

In April 2026, the long-awaited reclassification of marijuana from a Schedule 1 drug (on par with heroin) to a Schedule 3 drug (comparable to Tylenol® with codeine) was announced by the Department of Justice. The historic rescheduling of medical marijuana will favorably impact the cannabis industry — and potentially could impact hospices and home care companies. This webinar will discuss what marijuana reclassification does (and does not) mean for the healthcare industry. Learn what this rescheduling means (or does not mean) for your organization’s marijuana policy, people, patients, testing program, terminations, accommodations, and other HR, HIPAA, and business issues. 

THIS WEBINAR WILL BENEFIT THE FOLLOWING AGENCIES:

• Hospice 
• Home Care
• Home Health
• Palliative Care

WHO SHOULD ATTEND? 

• Compliance
• HR
• Training
• Legal
• Managers and executives
• Anyone responsible for workplace policy and compliance

TAKE-AWAY TOOLKIT

• Employee training log
• Interactive quiz
• PDF of slides and speaker’s contact info for follow-up questions
• Attendance certificate provided to self-report CE credits

NOTE: All materials are subject to copyright. Transmission, retransmission, or republishing of any webinar to other institutions or those not employed by your institution is prohibited. Print materials may be copied for eligible participants only. 

Presented By

Nancy Flynn

The ePolicy Institute™, Business Writing Institute™ & Marijuana Policy Institute™